LFCR · Healthcare · $246M
$6.57-0.30%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
12/'26
6/'26 vs prev quarter
Among 60 Drug Manufacturers - Specialty & Generic peers
Quarterly Revenue Growth
“이번 분기 매출은 3,420만 달러로 전년 동기 대비 6.2% 줄었지만, 회사는 2027년부터 최대 고객사의 필/피니시 주문량이 2배, 2028”
In the company's words · 2026 2분기 earnings call